References
WHO Online Tuberculosis Database. www.who.int/tb/country/ data/profiles (Accesed 21.07.15).
García-Casalla M, Fernández-Baca V, Juan-Mas A, et al. Use of Quantiferon-TB-Gold in Tube® test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice. Enferm Infecc Microbiol Clin 2013; 31: 76–81.
Gisondi P, Pezzolo E, Lo Cascio G, Girolomoni G. Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy. Br J Dermatol 2014; 171: 884–90.
Hewitt RJ, Francis M, Singanayagam A, Min Kon O. Screening tests for tuberculosis before starting biological therapy. BJM 2015; 350: h1060.
Latorre I, Carrascosa JM, Vilavella M, et al. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis. J Infect 2014; 69: 600–6.
Mir-Viladrich I, Daudén-Tello E, Solano-López G, et al. Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment. Arch Bronconeumol 2016; 52: 36–45.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Martinez-Lopez, A., Ruiz-Villaverde, R. Latent tuberculosis infection: diagnostic update before introduction of biological drugs. Eur J Dermatol 26, 307–308 (2016). https://doi.org/10.1684/ejd.2016.2750
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2016.2750